Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.17
+1.81 (3.90%)
Dec 10, 2025, 12:18 PM EST - Market open
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 21.94B | 328.11M |
| Mar 31, 2025 | 21.01B | 83.59M |
| Dec 31, 2024 | 19.92B | 96.69M |
| Sep 30, 2024 | 18.36B | 103.08M |
| Jun 30, 2024 | 17.30B | 78.60M |
| Mar 31, 2024 | 16.64B | 426.52M |
| Dec 31, 2023 | 15.54B | 460.20M |
| Sep 30, 2023 | 14.13B | 361.64M |
| Jun 30, 2023 | 12.79B | 647.65M |
| Mar 31, 2023 | 11.72B | 856.15M |
| Dec 31, 2022 | 10.51B | 1.16B |
| Sep 30, 2022 | 9.71B | 1.42B |
| Jun 30, 2022 | 8.91B | 1.44B |
| Mar 31, 2022 | 8.33B | 1.46B |
| Dec 31, 2021 | 7.73B | 1.42B |
| Sep 30, 2021 | 7.30B | 1.47B |
| Jun 30, 2021 | 6.78B | 1.60B |
| Mar 31, 2021 | 6.67B | 1.57B |
| Dec 31, 2020 | 6.82B | 1.62B |
| Sep 30, 2020 | 6.81B | 1.74B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.